GE HealthCare Technologies Inc (GEHC)
67.09
-2.28
(-3.29%)
USD |
NASDAQ |
May 06, 16:00
68.06
+0.97
(+1.45%)
After-Hours: 06:00
Key Stats
Price and Performance | |
---|---|
Market Cap | 30.72B |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | -15.79% |
Valuation | |
PE Ratio | 14.12 |
PE Ratio (Forward) | Upgrade |
PS Ratio | 1.555 |
Price to Book Value | 3.344 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | 0.035 |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 0.9534 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | -- |
Profile
Edit
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company’s sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%). |
URL | https://www.gehealthcare.com |
Investor Relations URL | https://investor.gehealthcare.com/ |
HQ State/Province | Illinois |
Sector | Health Care |
Industry | Health Care Equipment & Supplies |
Next Earnings Release | Jul. 31, 2025 (est.) |
Last Earnings Release | Apr. 30, 2025 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | Apr. 25, 2025 |
Ratings
Profile
Edit
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company’s sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%). |
URL | https://www.gehealthcare.com |
Investor Relations URL | https://investor.gehealthcare.com/ |
HQ State/Province | Illinois |
Sector | Health Care |
Industry | Health Care Equipment & Supplies |
Next Earnings Release | Jul. 31, 2025 (est.) |
Last Earnings Release | Apr. 30, 2025 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | Apr. 25, 2025 |